Biochemical Efficacy of Sodium–Glucose Cotransporter 2 Inhibitors by Cardiovascular Risk Profile and Volume Status in a Real-World Diabetic Population

Despite large-scale randomized clinical trials (RCTs) highlighting a consistent prognostic benefit of sodium–glucose cotransporter 2 inhibitors (SGLT2is) both in diabetic patients at high cardiovascular risk and in those with heart failure, there is relative paucity of data on their biochemical effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Gitto, Mauro, Kotinas, Alexios S., Terzi, Riccardo, Oliva, Angelo, Zagoreo, Jorgele, Reimers, Bernhard, Stefanini, Giulio G., Mirani, Marco, Favacchio, Giuseppe, Condorelli, Gianluigi, Panico, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of Cardiovascular Pharmacology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249071/
https://www.ncbi.nlm.nih.gov/pubmed/35436244
http://dx.doi.org/10.1097/FJC.0000000000001280

Ejemplares similares

Ejemplares similares